Teladoc Health, Inc. reported $2.51B of revenue over the trailing twelve months, −1.5% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.51B (to Q1 2026). Net Income: −$171M, trailing twelve months to Q1 2026. Free Cash Flow: $280M, trailing twelve months to Q1 2026. Op Margin: −8.1%, trailing twelve months to Q1 2026.

TDOCTeladoc Health, Inc.

HealthcareUSD

$6.33

$4.4752 weeks$9.71

TDOC as reported

Teladoc Health, Inc. reported $2.51B of revenue over the trailing twelve months, −1.5% on the year before. 10 reported series are charted on this page, each one as filed.

$2.51B

Revenue, trailing twelve months · to Q1 2026 · −1.5% against the twelve months before

Net Income: −$171M
Net Income · −83% year on year · trailing twelve months to Q1 2026
Free Cash Flow: $280M
Free Cash Flow · −2.8% year on year · trailing twelve months to Q1 2026
Op Margin: −8.1%
Op Margin · trailing twelve months to Q1 2026

Every series Ryufin has for TDOC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.51B	−1.5%	Q1 2026
Net Income	−$171M	−83%	Q1 2026
EPS	−$0.97	−84%	Q1 2026
Gross Margin	69%	n/a	Q1 2026
Op Margin	−8.1%	n/a	Q1 2026
Net Margin	−6.8%	n/a	Q1 2026
ROE	−14%	n/a	Q1 2026
ROA	−7.0%	n/a	Q1 2026
ROIC	−2.8%	n/a	Q4 2021 · 17 quarters behind
Free Cash Flow	$280M	−2.8%	Q1 2026